Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page

T cells
in AS, 499, 1277
autoimmune disease induction by microbial pathogens and, 458
in bone marrow transplantation in experimental antiphospholipid syndrome, 115
CD4, 384, 577
CD28, 649
cytotoxic, 477
epitope mapping by, of U1-A RNP, 1170
HTLV, 458, 690
immunosuppressive drugs during pregnancy and, 1722
lymphoma in, carpal tunnel syndrome due to, 1707
polyclonal, cytolytic activity of, in SLE, 506
in RA, 96, 254, 384, 477, 577, 649, 1242, 1701
receptors for, 91, 577, 649, 1242, 1277
in sacroiliitis, 499
synovial, IL-10 and, 946
tissue-infiltrating, 1242
Vβ genes, in MRL/lpr mice with Sjogren's syndrome, 1077
Tactoids, in pseudoseptic inflammatory knee effusion in sickle cell disease, 284
TAP genes, Reiter's syndrome and, 684
Tarsal disease, in juvenile AS, 835
Teased fiber preparation, to study peripheral neuropathy with necrotizing vasculitis in, 1618
Telangiectasias, diltiazem in calcinosis and, 1646
Telephone contact, in guidelines for medical management of OA, 1535
Telephone interviews, work disability in RA and, 1630
Temporal arteritis
See also giant cell arteritis
anemia in, 434
brain abscess mimicking, 1710
infection and onset of, 374
Temporal dimensions of fatigue, in SLE, 826
Tender points, cerebral blood flow, pain and, in women with fibromyalgia, 926
Tenderness, joint, in RA, 38, 601, 727, 1107, 1177, 1568
Tendons
Achilles, traumatic rupture of, 736
extensor, tenosynovitis in, 736
finger, 786
flexor sheath, 786
margins, 786
supraspinatous, rotator cuff tear and, 288
tears, 786
ultrasonography of, 736, 786
Tenidap
in experimental canine OA, 1290
in RA, 29, 1447
Tenosynovitis
extensor tendon, 736
of flexor tendons, in RA, 786
ultrasonography of, 736, 786
Teratogenesis, immunosuppressive drugs during pregnancy and, 1722
Tertiary care centers, patient subsets in SLE in, 1475
Th1, Th2, Th0 cells, synovial T cells, IL-10 and, 946
Th2 cytokines, in pathogenesis of spondylarthropathies, 1547
Thalamus, cerebral blood flow, pain and, in women with fibromyalgia, 926
Thigh
muscle in, MRI/MRS in DM and, 68
pain, lumbar spinal stenosis and, 1236
Thiopurine methyltransferase deficiency, in azathioprine toxicity in RA, 142
Thiouric acid, immunosuppressive drugs during pregnancy and, 1722
35-kd synovial antigens, antibodies to synovial antigens in early RA and, 1418
Thoracoscopic lung biopsy, antineutrophil cytoplasmic antibody-
negative pulmonary capillaritis, circulating primed neutrophils and, 1855
Thr, Arg, Glu, Leu, Asp amino acid sequence, MHC class II genes, anti-U1 snRNP antibody and, 396
3,7-dimethyl-1-8-cyclopentyl-dipropylxanthine, antiinflammatory mechanism of adenosine regulators and, 1040
3-B-3 monoclonal antibodies
in detecting biochemical markers of arthritis, 655
glycosaminoglycan epitopes in knee joint fluid after trauma and, 953
Thrombocytopenia
antibody-mediated heparin-induced, IgG receptors and, 306
in bone marrow transplantation in antiphospholipid syndrome, 115
parvovirus B19 infection, chronic fatigue syndrome and, 638
Thromboplastin time, partial, in bone marrow transplantation in antiphospholipid syndrome, 115
Thrombosis
human monoclonal antiphospholipid antibody and, 1068
lupus-associated, cross-reactivity of anticardiolipin autoantibodies with oxidized low-density lipoprotein and, 1382
Thumb, incidence of OA of, in an HMO, 1134
Thymus
autoimmune disease induction by microbial pathogens and, 458
Mi-2 autoantigen in DM and, 123
Tibia, distal, directed knee examination, cartilage abnormalities and, 917
Tibial plateau, tenidap in experimental canine OA and, 1290
Tibiofemoral compartment
directed knee examination, cartilage abnormalities and, 917
hyaluronic acid in OA in, 760
Tibiofemoral joint, knee OA in, in athletes, 539
Tibiofemoral OA, hyaluronic acid in, 760
Ticks, Lyme borreliosis and, 565
Tight skin mouse, scleroderma in, 1791
Tiludronate, etidronate and, in Paget's disease of bone, 851
Tissue
adipose, 1791
antigens, 301, 458
brain, spin-spin relaxation of, in SLE, 810
cytokines, early response genes and, 877
damage to, autoimmune disease induction by microbial pathogens and, 458
degradation of, 82, 1678
dermis, 1791
fetal, immunosuppressive drugs during pregnancy and, 1722
inflammation of, nitric oxide synthase in articular chondrocytes in pathogenesis of swelling and, 1529
injury to, 877
joint and connective tissue ultrasonography of, 736
lung, 939
in OA, 413, 525
peripheral lymphoid, IL-1 receptor antagonist in SLE and, 1055
in RA, 82, 151, 477, 492, 577, 969, 1031
scleroderma in Tsk2 mouse and, 1791
soft, 517, 736, 806
in SSc, 406, 517, 939
stromelysin and, 173, 969, 1031, 1678
substance P and calcitonin gene-relate peptide in, in rat adjuvant arthritis, 699
swelling, 173
tuberculous and foreign-body granulomatous reactions involving a total knee prothesis and, 1325
Yersinia enterocolitica adhesin YadA, on collagen and, 1282
Tissue-infiltrating T cells, T cell receptors in RA and, 1242
Toluidine blue antibody staining, to study stromelysin degradation of cartilage, 1678
Tophaceous gout, spinal involvement in, 139
Topical analgesics, guidelines for medical management of OA and, 1541
Total knee arthroplasty, proteoglycans in articular cartilage in OA and RA after, 660
Total knee prosthesis, tuberculous and foreign-body granulomatous reaction to, 1325
Total oxidative capacity, MRI/MRS in DM and, 68
Toxic epidermal necrolysis, after sulfasalazine in psoriatic arthritis, 573
Toxic shock syndrome toxin 1 (TSST-1), staphylococcal superanti-
gen, autoimmune disease induction by microbial pathogens and, 458
Toxicity
azathioprine, 179
CAMPATH-1H, 1589
guidelines for medical management of OA and, 1535
hepato-, 1115
immunosuppressive drugs during pregnancy and, 1722
MTX, 297, 608, 1014, 1115, 1173, 1799
in RA, 142, 297, 318, 334, 1014, 1115, 1173, 1187, 1589, 1799
Toxins, staphylococcal superantigen TSST-1, autoimmune disease induction by microbial pathogens and, 458
Toxoplasma gondii cytomegalovirus, enteroviral RNA, bacterial DNA and, in juvenile DM, 1513
Tracheal stenosis, secondary to DISH, 296
Transactivation, autoimmune disease induction by microbial pathogens and, 458
Transaminases, IL-2 diphtheria fusion protein (DAB486IL-2) in refractory RA and, 1177
Transcriptase
polymerase chain reaction reverse, 413, 1513
in situ reverse, to study granzyme A and perforin mRNA in RA synovium, 477
Transcription factors
latent, early response genes and, 877
nuclear factor κB in rheumatoid synovium, 1762
Transcriptional activation, Mi-2 autoantigen in DM and, 1389
Transferase-conjugated agarose beads, recombinant HRES-1/
gluthione-S-, HRES-1 antibodies and, in SLE and overlap syndromes, 1660
Transferrin substrate, 3H-labeled, Arg-Gly-Asp (RGD), IL-1, chondrocyte matrix metalloproteinase synthesis and, 1304
Transforming growth factor β (TGFβ)
chondrocytes in aging and development and, 960
IgG receptors in autoimmune disease and, 306
1, in hyaluronan synthesis in human synovial lining cells, 669
in sacroiliitis in AS, 499
Transfusions
exchange, immunosuppressive drugs during pregnancy and, 1722
reactions to, leukoagglutination, IgG receptors in autoimmune disease and, 306
red blood cell, in Lyme borreliosis, 565
Transgenic mice
autoimmune disease induction by microbial pathogens and, 458
HLA-B51, peripheral blood neutrophils in Behcet's disease and, 426
Transient fever/chills, IL-2 diphtheria fusion protein (DAB486IL-2) in refractory RA and, 1177
Transmembrane regions, IgG receptors in autoimmune disease and, 306
Transmitted bony crepitus, directed knee examination, cartilage abnormalities and, 917
Transplantation
biology, 1722
bone marrow cell, in experimental antiphospholipid syndrome, 115
immunosuppressive drugs during pregnancy and, 1722
renal, rejection in, IgG receptors in autoimmune disease and, 306
Transporters associated with antigen processing (TAP) genes, Reiter's syndrome and, 684
Transverse myelitis, cognitive deficit in rheumatic diseases and, 1361
Trauma
clenched fist syndrome and, 57
glycosaminoglycan epitopes in knee joint fluid after, 953
head, cognitive deficit in rheumatic diseases and, 1361
joint, 420
OA and, 420, 539, 1290
Raynaud's phenomenon, scleroderma and, 1
Traumatic rupture, of Achilles tendon, joint and connective tissue ultrasonography of, 736
Triamcinolone acetonide, somatostatin in experimental arthritis and, 1687
Triphosphate, inositol 1,3,4-, IgG receptors in autoimmune disease and, 306
Trochanter, radiographic hip OA, bone mineral density and, 907
Tryptophan, cognitive deficit in rheumatic diseases and, 1361
Tsk2 mouse, scleroderma in, 1791
Tuberculosis, soft tissue, of thumb, joint and connective tissue ultrasonography of, 736
Tuberculous granulomatous reaction, involving a total knee prosthesis, 1325
Tumor necrosis factor (TNF)
early response genes and, 877
receptors for, in JRA, 211
Tumor necrosis factor α (TNFα)
antiinflammatory mechanism of adenosine regulators and, 1040
E-selectin in SSc and, 406
IL-1 and, in experimental arthritis in mice, 164
in JRA, 211
proteoglycan synthesis in canine OA and, 525
in RA, 29, 151, 601, 1107, 1457
in sacroiliitis in AS, 499
TGFβ1 in hyaluronan synthesis in synovial lining cells and, 669
vitamin B6 in rheumatoid cachexia and, 105
28-joint count, in RA, 38, 44
Twin studies
autoantibodies in SSc, 1845
occurrence of AS in, in Finland, 381
osteoporosis in RA, 806
2-chlorodeoxyadenosine, oral, in psoriatic arthritis, 1604
2`,7`-dichlorofluorescin diacetate, peripheral blood neutrophils in Behcet's disease and, 426
Two-color flow cytometry, to study CD28 cells in RA, 649
Two-color immunofluorescence
to study CD28 cells in RA, 649
to study T cell receptor Vβ genes in MRL/lpr mice with Sjogren's syndrome, 1077
218-kd nuclear protein, Mi-2 autoantigen in DM and, 1389
tyk2 kinase, cytokines, early response genes and, 877
Tyrosine
kinase, cytokines, early response genes and, 877
MHC class II genes, anti-U1 snRNP antibody and, 396
phosphorylation, 306, 877